Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9
This study found that eutopic endometrial tissue from women with endometriosis exhibits increased proteolytic activity, specifically elevated matrix metalloproteinase-9 secretion and an imbalance with its inhibitor TIMP-1, compared to women without endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (44)
- Characterization of lymphocyte subpopulations and T cell activation in endometriosis via openalex
- Effect of danazol on the immunocompetent cells in the eutopic endometrium in patients with endometriosis: a multicenter cooperative study via openalex
- Endometrial anomalies in women with endometriosis via openalex
- Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women via openalex
- Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions via openalex
- Expression of metalloproteinase-9 in ectopic endometrium in women with endometriosis via openalex
- Immunobiology of endometriosis via openalex
- Increased concentrations of cathepsin D in peritoneal fluid from women with endometriosis via openalex
- Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis via openalex
- Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants via openalex
- Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness via openalex
- Matrix metalloproteinases and endometriosis via openalex
- O-037 Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis via openalex
- Paracrine regulation of matrix metalloproteinase expression in endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Status of current research on endometriosis. via openalex
- Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice via openalex
- Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy via openalex
- W2021293531 via openalex
- W2012071401 via openalex
- W2037583107 via openalex
- W2040348117 via openalex
- W2009255017 via openalex
- W2074771496 via openalex
- W2077483002 via openalex
- W2082934999 via openalex
- W2009130386 via openalex
- W2085370734 via openalex
- W2000537146 via openalex
- W1964455098 via openalex
- W2110828317 via openalex
- W2128930486 via openalex
- W2136084194 via openalex
- W2147862420 via openalex
- W2154401382 via openalex
- W1649452503 via openalex
- W2167709602 via openalex
- W2204640292 via openalex
- W1503337666 via openalex
- W2414507481 via openalex
- W136766227 via openalex
- W2434334136 via openalex
- W70839425 via openalex
Cited by (50)
- Shared Biology Underlying Benign Endometrial Diseases and Endometrial Cancer: Current Knowledge and Future Prospectives 2026
- MMP2/TIMP2 ratio as a measurable indicator for differentiating diffuse adenomyosis, ovarian endometriosis, and their co-existence 2025
- The activity of Matrix Metalloproteinase-2 (MMP-2) and Tissue Inhibitors of Metalloproteinase-2 (TIMP-2) that are associated with the degree of endometrioma tissue invasion transplanted onto the Chorioallantoic Membrane (CAM) 2023
- Protective Effect of Ursodeoxycholic Acid in Experimental Endometriosis Induced Rat Model 2023
- MMP-9 and TIMP-1 Promote Extracellular Matrix Remodeling in the Formation of Ovarian Endometrioma: in vitro Study on Chicken Chorioallantoic Membrane 2023
- A Traditional Chinese Medicine for the Treatment of Endometrial Hyperplasia via Regulating the HPO Axis in Rats 2022
- Melatonin in Endometriosis: Mechanistic Understanding and Clinical Insight 2022
- Significance of metabolomic disorders in infertility and miscarriage in patients with endometriosis 2022
- IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression 2022
- Molecular mechanisms of a traditional Chinese medicine in the treatment of dysfunctional uterine bleeding 2021
- Expression of Matrix Metalloproteinases and Their Inhibitors in Endometrium: High Levels in Endometriotic Lesions 2020
- Doxycycline reduces MMP-2 activity and inhibits invasion of 12Z epithelial endometriotic cells as well as MMP-2 and -9 activity in primary endometriotic stromal cells in vitro 2019
- Significance of matrix metalloproteinase-9 expression in the ectopic endometrial tissue of women with endometriosis 2019
- The Effect of Imbalanced Progesterone Receptor-A/-B Ratio on Gelatinase Expressions in Endometriosis 2019
- The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) 2018
- Increased Expression Levels of Metalloprotease, Tissue Inhibitor of Metalloprotease, Metallothionein, and p63 in Ectopic Endometrium: An Animal Experimental Study 2018
- Complex Mechanisms of Matrix Metalloproteinases Involvement in Endometrial Physiology and Pathology—An Update 2017
- ASSOCIATION AND INTERACTION OF POLYMORPHISMS IN ANGIOGENESIS GENES INVOLVED IN ENDOMETRIOSIS. 2017
- Intracellular Wnt/Beta-Catenin Signaling Underlying 17beta-Estradiol-Induced Matrix Metalloproteinase 9 Expression in Human Endometriosis 2016
- Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis? 2016
- Endometrial biomarkers for the non-invasive diagnosis of endometriosis 2016
- Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis 2015
- Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence 2015
- Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis 2015
- Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model 2015
- Development of peritoneal endometriosis: Characterisation of immune environment in peritoneal endometriotic lesions 2015
- Targeting the Wnt/β-catenin pathway in endometriosis: a potentially effective approach for treatment and prevention 2014
- Melatonin causes regression of endometriotic implants in rats by modulating angiogenesis, tissue levels of antioxidants and matrix metalloproteinases 2014
- Roles of regulatory T cells in endometriosis-associated infertility 2014
- 1-alpha,25-dihydroxyvitamin D3 regresses endometriotic implants in rats by inhibiting neovascularization and altering regulation of matrix metalloproteinase 2014
- Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis 2013
- Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology 2013
- The effects of ranibizumab on surgically induced endometriosis in a rat model: a preliminary study 2013
- In vitro effects of a small-molecule antagonist of the Tcf/ß-catenin complex on endometrial and endometriotic cells of patients with endometriosis 2013
- Endometriosis and Angiogenic Factors 2012
- The Local Immune Mechanisms Involved in the Formation of Endometriotic Lesions 2012
- Expression of<i>membrane type-2</i>and<i>-3 matrix metalloproteinases</i>in eutopic endometrium of women with advanced endometriosis 2011
- Pelvic Mechanisms Involved in the Pathophysiology of Pain in Endometriosis 2011
- Distinct expression of the soluble and the membrane-bound forms of interleukin-1 receptor accessory protein in the endometrium of women with endometriosis 2011
- Mediadores inflamatórios na dor pélvica crônica identificação de possíveis marcadores séricos da doença 2010
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases 2010
- Disrupted cell cycle control in cultured endometrial cells from patients with endometriosis harboring the progesterone receptor polymorphism PROGINS 2009
- Association between MMP1 and MMP9 activities and ICAM1 cleavage induced by tumor necrosis factor in stromal cell cultures from eutopic endometria of women with endometriosis 2009
- Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 2009
- Atorvastatin causes regression of endometriotic implants in a rat model 2009
- Doxycycline causes regression of endometriotic implants: a rat model 2009
- Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium 2008
- Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis 2008
- Microanatomy and function of the eutopic endometrium in women with endometriosis 2008
- Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis 2008
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:02:29.018211+00:00